Hyloris Pharmaceuticals SA: Hyloris Launches Equity Offering by Means of a Private Placement Via an Accelerated Bookbuild Offering

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, AUSTRALIA, SOUTH AFRICA OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF

Related Keywords

Australia ,Japan ,United States ,United Kingdom ,Belgium ,South Africa ,Canada ,Switzerland ,Belgian , ,Belgian Companies ,Linkedin ,European Parliament ,Gossler Co ,Hyloris Pharmaceuticals ,European Union Withdrawal Agreement ,Swiss Federal Act On Financial Services Finanzdienstleistungsgesetz ,Stifel Nicolaus Europe Limited ,Belgian Code Of Companies ,Hyloris Pharmaceuticals Sa Euronext Brussels ,European Union Withdrawal ,Company The Committee ,Association Code ,Company Or Hyloris ,Euronext Brussels ,Joint Global Coordinators ,Joint Bookrunners ,Noshaq Partners ,Belgian Code ,Qualified Investors ,Professional Clients ,United Kingdom Relevant Persons ,United States Securities Act ,Member State ,European Economic Area ,Relevant Member State ,Prospectus Regulation ,European Union ,Withdrawal Agreement ,Kingdom Prospectus ,Kingdom Relevant ,Swiss Federal Act ,Financial Services ,Hyloris ,Pharmaceuticals ,Aunches ,Equity ,Offering ,Jeans ,Private ,Placement ,Ccelerated ,Ookbuild ,